240 related articles for article (PubMed ID: 19166794)
21. [LADA--latent autoimmune diabetes in adults].
Szelachowska M
Endokrynol Pol; 2007; 58(3):246-51. PubMed ID: 17940991
[TBL] [Abstract][Full Text] [Related]
22. Latent autoimmune diabetes in adults (LADA) should be less latent.
Fourlanos S; Dotta F; Greenbaum CJ; Palmer JP; Rolandsson O; Colman PG; Harrison LC
Diabetologia; 2005 Nov; 48(11):2206-12. PubMed ID: 16193284
[TBL] [Abstract][Full Text] [Related]
23. [Diabetes mellitus--differential diagnosis].
Hummel M; Füchtenbusch M
MMW Fortschr Med; 2006 May; 148(20):47-50. PubMed ID: 16805191
[TBL] [Abstract][Full Text] [Related]
24. The role of C-peptide levels in screening for latent autoimmune diabetes in adults.
Bell DS; Ovalle F
Am J Ther; 2004; 11(4):308-11. PubMed ID: 15266224
[TBL] [Abstract][Full Text] [Related]
25. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.
Thunander M; Petersson C; Jonzon K; Fornander J; Ossiansson B; Torn C; Edvardsson S; Landin-Olsson M
Diabetes Res Clin Pract; 2008 Nov; 82(2):247-55. PubMed ID: 18804305
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing type 1 and type 2 diabetes at diagnosis. What is the problem?
Rosenbloom AL
Pediatr Diabetes; 2007 Apr; 8(2):51-2. PubMed ID: 17448126
[No Abstract] [Full Text] [Related]
27. The utility of the C-peptide in the phenotyping of patients candidates for pancreas transplantation.
Esmatjes E; Fernández C; Rueda S; Nicolau J; Chiganer G; Ricart MJ; Junca E; Fernández-Cruz L
Clin Transplant; 2007; 21(3):358-62. PubMed ID: 17488385
[TBL] [Abstract][Full Text] [Related]
28. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults.
Brophy S; Yderstraede K; Mauricio D; Hunter S; Hawa M; Pozzilli P; Schernthaner G; Schloot N; Buzzetti R; Davies H; Leslie D; Williams R;
Diabetes Care; 2008 Mar; 31(3):439-41. PubMed ID: 18083788
[TBL] [Abstract][Full Text] [Related]
29. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
[TBL] [Abstract][Full Text] [Related]
30. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
[TBL] [Abstract][Full Text] [Related]
31. [Obesity in children and adolescents and diabetes].
Nazim J; Starzyk J
Przegl Lek; 2009; 66(1-2):96-9. PubMed ID: 19485265
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of microvascular complications in metabolic syndrome in comparison to type 2 diabetes mellitus.
Ahamed A; Shantha GP; Agarwal G; Senthil N; Paunikar N; Sudhakar MK
J Indian Med Assoc; 2008 Sep; 106(9):583-4, 586, 588. PubMed ID: 19552085
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation for the prevention of SPIDDM and LADA.
Pozzilli P; Guglielmi C
Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
[TBL] [Abstract][Full Text] [Related]
34. [Significance of the determination of C-peptide in type 2 diabetes].
Perusicová J; Skachová J
Vnitr Lek; 1987 Feb; 33(2):134-9. PubMed ID: 3548038
[No Abstract] [Full Text] [Related]
35. Latent autoimmune diabetes of adults (LADA).
Ola TO; Gigante A; Leslie RD
Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):163-7. PubMed ID: 16580583
[No Abstract] [Full Text] [Related]
36. [Insulin dependent (type 1) diabetes mellitus in advanced age].
Halmos T; Suba I; Kautzky L
Orv Hetil; 1998 Nov; 139(47):2829-31. PubMed ID: 9846062
[TBL] [Abstract][Full Text] [Related]
37. [Type 1 and type 2 diabetes mellitus in Germany. An epidemic in all age groups].
Danne T
MMW Fortschr Med; 2004 May; 146(20):27. PubMed ID: 15344728
[No Abstract] [Full Text] [Related]
38. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy.
Yu SH; Park S; Kim HS; Park SY; Yim CH; Han KO; Yoon HK; Jang HC; Chung HY; Kim SH
Diabetes Metab Res Rev; 2009 May; 25(4):329-34. PubMed ID: 19405080
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA).
Martinell M; Dorkhan M; Stålhammar J; Storm P; Groop L; Gustavsson C
J Diabetes Complications; 2016; 30(8):1456-1461. PubMed ID: 27593902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]